Accuray | ARAY - Ebitda


Accuray reported $-685K in EBITDA for its fiscal quarter ending in September of 2024.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 19.86M 2.06M Dec/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 27.88M 2.77M Dec/2025
Surmodics USD 3.43M 1.9M Jun/2025
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Trinity Biotech USD -9.6M 7.64M Dec/2024